New York State Common Retirement Fund lifted its stake in shares of Proto Labs, Inc. (NYSE:PRLB) by 2.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 651,475 shares of the industrial products company’s stock after acquiring an additional 13,206 shares during the quarter. New York State Common Retirement Fund owned approximately 2.44% of Proto Labs worth $52,313,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently modified their holdings of PRLB. Teachers Advisors LLC raised its position in shares of Proto Labs by 3.7% during the first quarter. Teachers Advisors LLC now owns 44,891 shares of the industrial products company’s stock worth $2,294,000 after acquiring an additional 1,607 shares during the last quarter. California Public Employees Retirement System bought a new position in shares of Proto Labs during the first quarter worth about $230,000. Dimensional Fund Advisors LP raised its position in shares of Proto Labs by 14.5% during the first quarter. Dimensional Fund Advisors LP now owns 351,431 shares of the industrial products company’s stock worth $17,958,000 after acquiring an additional 44,535 shares during the last quarter. UBS Group AG raised its position in shares of Proto Labs by 128.0% during the first quarter. UBS Group AG now owns 2,603 shares of the industrial products company’s stock worth $133,000 after acquiring an additional 11,895 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. increased its holdings in Proto Labs by 4.4% in the first quarter. Schwab Charles Investment Management Inc. now owns 104,131 shares of the industrial products company’s stock worth $5,322,000 after purchasing an additional 4,342 shares in the last quarter.

A number of equities research analysts have weighed in on the company. Craig Hallum set a $92.00 target price on Proto Labs and gave the stock a “hold” rating in a report on Monday, November 27th. Zacks Investment Research upgraded Proto Labs from a “hold” rating to a “buy” rating and set a $96.00 target price for the company in a report on Friday, November 3rd. Finally, BidaskClub downgraded Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Friday, October 6th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Proto Labs currently has a consensus rating of “Hold” and a consensus price target of $75.00.

In other news, VP John B. Tumelty sold 13,556 shares of the business’s stock in a transaction that occurred on Wednesday, November 22nd. The stock was sold at an average price of $92.07, for a total transaction of $1,248,100.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Rainer Gawlick sold 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, November 21st. The shares were sold at an average price of $90.31, for a total value of $135,465.00. Following the sale, the director now owns 6,925 shares of the company’s stock, valued at approximately $625,396.75. The disclosure for this sale can be found here. Insiders own 7.78% of the company’s stock.

Shares of Proto Labs, Inc. (NYSE:PRLB) traded up $1.35 during mid-day trading on Wednesday, reaching $97.35. The company’s stock had a trading volume of 198,700 shares, compared to its average volume of 193,074. The company has a market capitalization of $2,558.00, a P/E ratio of 54.86, a P/E/G ratio of 2.41 and a beta of 1.06. Proto Labs, Inc. has a 1-year low of $48.00 and a 1-year high of $97.63.

Proto Labs (NYSE:PRLB) last issued its earnings results on Thursday, October 26th. The industrial products company reported $0.56 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.04. The business had revenue of $88.10 million during the quarter, compared to the consensus estimate of $85.68 million. Proto Labs had a return on equity of 11.63% and a net margin of 14.53%. The firm’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.51 earnings per share. sell-side analysts expect that Proto Labs, Inc. will post 1.9 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.thecerbatgem.com/2017/12/06/new-york-state-common-retirement-fund-has-52-31-million-stake-in-proto-labs-inc-prlb.html.

About Proto Labs

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Stock Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related stocks with our FREE daily email newsletter.